Annual Current Assets
$28.18 M
-$15.90 M-36.07%
December 31, 2023
Summary
- As of February 8, 2025, RGLS annual total current assets is $28.18 million, with the most recent change of -$15.90 million (-36.07%) on December 31, 2023.
- During the last 3 years, RGLS annual current assets has fallen by -$8.55 million (-23.28%).
- RGLS annual current assets is now -82.92% below its all-time high of $164.95 million, reached on December 31, 2014.
Performance
RGLS Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$91.69 M
-$8.65 M-8.62%
September 30, 2024
Summary
- As of February 8, 2025, RGLS quarterly total current assets is $91.69 million, with the most recent change of -$8.65 million (-8.62%) on September 30, 2024.
- Over the past year, RGLS quarterly current assets has dropped by -$8.65 million (-8.62%).
- RGLS quarterly current assets is now -44.42% below its all-time high of $164.95 million, reached on December 31, 2014.
Performance
RGLS Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
RGLS Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.1% | -8.6% |
| 3 y3 years | -23.3% | +78.4% |
| 5 y5 years | +46.0% | +369.5% |
RGLS Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.8% | at low | -9.6% | +225.4% |
| 5 y | 5-year | -56.8% | at low | -9.6% | +248.5% |
| alltime | all time | -82.9% | +46.0% | -44.4% | +416.9% |
Regulus Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $91.69 M(-8.6%) |
| Jun 2024 | - | $100.34 M(-1.1%) |
| Mar 2024 | - | $101.45 M(+260.0%) |
| Dec 2023 | $2.57 M(-2.5%) | $28.18 M(-19.7%) |
| Sep 2023 | - | $35.08 M(-15.2%) |
| Jun 2023 | - | $41.36 M(+19.7%) |
| Mar 2023 | - | $34.56 M(-21.6%) |
| Dec 2022 | $2.64 M(-18.1%) | $44.08 M(-10.7%) |
| Sep 2022 | - | $49.37 M(-3.9%) |
| Jun 2022 | - | $51.40 M(-11.3%) |
| Mar 2022 | - | $57.93 M(-11.2%) |
| Dec 2021 | $3.22 M(+268.3%) | $65.23 M(+63.1%) |
| Sep 2021 | - | $39.99 M(-13.7%) |
| Jun 2021 | - | $46.31 M(+26.8%) |
| Mar 2021 | - | $36.54 M(-0.5%) |
| Dec 2020 | $874.00 K(-47.8%) | $36.73 M(+39.6%) |
| Sep 2020 | - | $26.31 M(-8.0%) |
| Jun 2020 | - | $28.59 M(-14.9%) |
| Mar 2020 | - | $33.61 M(-16.8%) |
| Dec 2019 | $1.67 M(-80.6%) | $40.41 M(+106.9%) |
| Sep 2019 | - | $19.53 M(-19.6%) |
| Jun 2019 | - | $24.28 M(+36.9%) |
| Mar 2019 | - | $17.74 M(-8.1%) |
| Dec 2018 | $8.63 M | $19.30 M(-24.2%) |
| Sep 2018 | - | $25.44 M(-35.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $39.23 M(-23.7%) |
| Mar 2018 | - | $51.43 M(-22.9%) |
| Dec 2017 | $11.07 M(-16.0%) | $66.74 M(-16.1%) |
| Sep 2017 | - | $79.57 M(+59.3%) |
| Jun 2017 | - | $49.94 M(-26.2%) |
| Mar 2017 | - | $67.65 M(-22.7%) |
| Dec 2016 | $13.19 M(+93.2%) | $87.47 M(-14.9%) |
| Sep 2016 | - | $102.83 M(-11.5%) |
| Jun 2016 | - | $116.23 M(+0.4%) |
| Mar 2016 | - | $115.76 M(-13.8%) |
| Dec 2015 | $6.83 M(+4.5%) | $134.26 M(-1.9%) |
| Sep 2015 | - | $136.81 M(-5.1%) |
| Jun 2015 | - | $144.09 M(-9.1%) |
| Mar 2015 | - | $158.52 M(-3.9%) |
| Dec 2014 | $6.53 M(+11.0%) | $164.95 M(+68.3%) |
| Sep 2014 | - | $98.02 M(-9.1%) |
| Jun 2014 | - | $107.88 M(-8.7%) |
| Mar 2014 | - | $118.23 M(+0.9%) |
| Dec 2013 | $5.88 M(+28.2%) | $117.18 M(-6.5%) |
| Sep 2013 | - | $125.29 M(+44.2%) |
| Jun 2013 | - | $86.87 M(-5.3%) |
| Mar 2013 | - | $91.77 M(-7.2%) |
| Dec 2012 | $4.59 M(+8.9%) | $98.93 M(+187.9%) |
| Sep 2012 | - | $34.36 M(+24.5%) |
| Jun 2012 | - | $27.60 M(-28.6%) |
| Dec 2011 | $4.21 M | $38.67 M |
FAQ
- What is Regulus Therapeutics annual total current assets?
- What is the all time high annual current assets for Regulus Therapeutics?
- What is Regulus Therapeutics annual current assets year-on-year change?
- What is Regulus Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly current assets year-on-year change?
What is Regulus Therapeutics annual total current assets?
The current annual current assets of RGLS is $28.18 M
What is the all time high annual current assets for Regulus Therapeutics?
Regulus Therapeutics all-time high annual total current assets is $164.95 M
What is Regulus Therapeutics annual current assets year-on-year change?
Over the past year, RGLS annual total current assets has changed by -$15.90 M (-36.07%)
What is Regulus Therapeutics quarterly total current assets?
The current quarterly current assets of RGLS is $91.69 M
What is the all time high quarterly current assets for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly total current assets is $164.95 M
What is Regulus Therapeutics quarterly current assets year-on-year change?
Over the past year, RGLS quarterly total current assets has changed by -$8.65 M (-8.62%)